Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.027 | 0.0114 | 0.0114 |
Brugia malayi | Fibulin-1 precursor | 0.0693 | 0.2342 | 1 |
Onchocerca volvulus | 0.027 | 0.0114 | 0.0473 | |
Loa Loa (eye worm) | zinc metalloproteinase toh-2 | 0.027 | 0.0114 | 0.0114 |
Onchocerca volvulus | Arrow homolog | 0.0623 | 0.1974 | 1 |
Brugia malayi | Matrixin family protein | 0.0283 | 0.0183 | 0.0782 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0693 | 0.2342 | 0.5 |
Echinococcus multilocularis | laminin | 0.0693 | 0.2342 | 0.2342 |
Brugia malayi | Zinc metalloproteinase toh-2 precursor | 0.027 | 0.0114 | 0.0488 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.0693 | 0.2342 | 0.2342 |
Brugia malayi | Nematode astacin protease protein 30 | 0.027 | 0.0114 | 0.0488 |
Loa Loa (eye worm) | hypothetical protein | 0.0623 | 0.1974 | 0.1974 |
Brugia malayi | Low-density lipoprotein receptor repeat class B containing protein | 0.0623 | 0.1974 | 0.8431 |
Brugia malayi | Nematode astacin protease protein 30 | 0.027 | 0.0114 | 0.0488 |
Loa Loa (eye worm) | DPY-31 protein | 0.027 | 0.0114 | 0.0114 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.215 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0252 | 0.0022 | 0.0022 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.0252 | 0.0022 | 0.0094 |
Echinococcus multilocularis | Tolloid protein 1 | 0.215 | 1 | 1 |
Loa Loa (eye worm) | matrixin family protein | 0.0259 | 0.006 | 0.006 |
Loa Loa (eye worm) | matrixin family protein | 0.0283 | 0.0183 | 0.0183 |
Brugia malayi | zinc metalloproteinase toh-2 precursor | 0.027 | 0.0114 | 0.0488 |
Echinococcus granulosus | matrix metallopeptidase 7 M10 family | 0.0425 | 0.0932 | 0.0932 |
Schistosoma mansoni | egf-like domain protein | 0.0623 | 0.1974 | 0.1974 |
Onchocerca volvulus | Matrilysin homolog | 0.0259 | 0.006 | 0.0195 |
Loa Loa (eye worm) | AStacin protease | 0.1344 | 0.5763 | 0.5763 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.0693 | 0.2342 | 0.5 |
Echinococcus multilocularis | matrix metallopeptidase 7 (M10 family) | 0.0425 | 0.0932 | 0.0932 |
Loa Loa (eye worm) | low-density lipoprotein receptor repeat class B containing protein | 0.0623 | 0.1974 | 0.1974 |
Onchocerca volvulus | Matrix metalloproteinase homolog | 0.0259 | 0.006 | 0.0195 |
Echinococcus multilocularis | fibrillin 1 | 0.0693 | 0.2342 | 0.2342 |
Loa Loa (eye worm) | hypothetical protein | 0.0693 | 0.2342 | 0.2342 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.0693 | 0.2342 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0623 | 0.1974 | 0.1974 |
Brugia malayi | astacin protease protein 30 | 0.027 | 0.0114 | 0.0488 |
Echinococcus granulosus | laminin | 0.0693 | 0.2342 | 0.2342 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.215 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0876 | 0.33 | 0.33 |
Loa Loa (eye worm) | hypothetical protein | 0.2062 | 0.954 | 0.954 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
C50 (functional) | = 5.3 uM | Inhibitory concentration against ethidium binding to DNA | ChEMBL. | 7205885 |
IC50 (functional) | = 60 nM | Inhibitory concentration of the compound to reduce the growth of L1210 cells by 50% after 70 h . | ChEMBL. | 3820217 |
IC50 (functional) | = 60 nM | Inhibitory concentration of the compound to reduce the growth of L1210 cells by 50% after 70 h . | ChEMBL. | 3820217 |
ID50 (functional) | = 26 nM | Concentration for inhibiting the growth of P-388 cells by 50% over 3 days was determined | ChEMBL. | 7143362 |
ID50 (functional) | = 26 nM | Concentration for inhibiting the growth of P-388 cells by 50% over 3 days was determined | ChEMBL. | 7143362 |
ID50 (functional) | = 60 nM | Concentration for inhibiting the growth of L1210 cells by 50% over 3 days was determined | ChEMBL. | 7143362 |
ID50 (functional) | = 60 nM | Concentration for inhibiting the growth of L1210 cells by 50% over 3 days was determined | ChEMBL. | 7143362 |
ILS (functional) | = 75 % | Maximum percent increase in life span of mice was determined by L1210 assay | ChEMBL. | 7205885 |
ILS (functional) | = 75 % | Maximum percent increase in life span of mice was determined by L1210 assay | ChEMBL. | 7205885 |
ILS (functional) | = 98 % | Percentage increase in life span was measured for P-388 cells in culture after interperitoneal administration of a dose of 30 mg/kg | ChEMBL. | 7143362 |
ILS (functional) | = 98 % | Percentage increase in life span was measured for P-388 cells in culture after interperitoneal administration of a dose of 30 mg/kg | ChEMBL. | 7143362 |
LD10 (ADMET) | = 60 mg kg-1 | Drug dose that is lethal to 10% of animals was measured | ChEMBL. | 7205885 |
LD10 (ADMET) | = 60 mg kg-1 | Drug dose that is lethal to 10% of animals was measured | ChEMBL. | 7205885 |
Log 1/D50 (functional) | = 4.08 | Drug concentration in mole/kg/day providing 50% extension of life in intraperitoneally implanted leukemia L1210 mice. | ChEMBL. | 7069706 |
Log 1/D50 (functional) | = 4.08 | Dose of the drug (mol /kg) providing a 50% life extension in L1210 assays when given at qd 1-5 schedule . | ChEMBL. | 3820217 |
Log 1/LD10 (ADMET) | = 3.85 | Compound concentration in mole/kg/day lethal to 10% of mice | ChEMBL. | 7069706 |
Log K (binding) | = 6.23 | Association constant for binding to poly [d(G-C)] | ChEMBL. | 7205885 |
Log K (binding) | = 6.36 | Association constant for binding to poly [d(A-T)] | ChEMBL. | 7205885 |
Log K (binding) | = 6.36 | Antitumor activity as association constant for DNA binding to poly (dA.dT) | ChEMBL. | 7143362 |
pKa | = 7.64 | Ionisation constant (pKa) | ChEMBL. | 7205885 |
pKa | = 7.64 | Ionization constant (pKa) | ChEMBL. | 7069706 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 3820217 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
4 literature references were collected for this gene.